Recro Pharma Stock Price (NASDAQ:REPH)

Add to My Stocks
$7.12 $0.01 (0.14%) REPH stock closing price Jan 20, 2017 (Closing)
Prev Close* : $7.13
Market Cap:
Day Low: $7.01
52 Week Low: $5.59
Open: $7.13
Volume: 94050
Day High: $7.27
52 Week High: $12.50

Latest Stock Market News

Latest Articles

Recro Pharma News - From Partners

REPH Stockcharts

View REPH PE ratio, PS ratio stocks charts and compare with peers.
REPH Chart
Note: Compare Recro Pharma stock price history with the index and industry peers.

Recro Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Recro Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

REPH Industry Peers

Company Price Change (%)
Cumberland Pharma (CPIX)5.90 (0%)
Aurinia (AUPH)2.530.05 (2.02%)
Catalent (CTLT)26.210.25 (0.96%)
Elite Pharma (ELTP)0.180 (0%)
Zogenix (ZGNX)8.950.35 (3.76%)
Trevena (TRVN)6.190.02 (0.32%)
Pernix Therapeutics (PTX)2.760.05 (1.78%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aralez Pharma (ARLZ)4.40.34 (8.37%)
Concert Pharma (CNCE)9.370.52 (5.88%)
AVADEL PHARMA (AVDL)10.310.4 (4.04%)
Nutraceutical International (NUTR)34.80.4 (1.16%)
Aratana Therapeutics (PETX)7.620.08 (1.06%)
La Jolla Pharma (LJPC)20.130.2 (1%)
Zoetis (ZTS)53.970.47 (0.88%)
Top gainers from Medical-Drugs industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Synergy Pharma (SGYP)5.910.5 (7.8%)
Achaogen (AKAO)17.551.29 (6.85%)
Cempra (CEMP)30.2 (6.25%)
Xencor (XNCR)21.741.01 (4.44%)
Endo International (ENDP)12.340.56 (4.34%)
Egalet (EGLT)5.020.22 (4.2%)
Durect (DRRX)1.180.05 (4.07%)
Top losers from Medical-Drugs industry
* As of Jan 21, 2017

Recro Pharma Financial Statements

income statement201520142013
Net Sales Or Revenues51.95M--
Net Income3.03M-16.13M-1.95M
Total Operating Expense30.86M11.86M1.08M
view Recro Pharma Inc income statement
balance sheet201520142013
Total Assets138.69M20.37M0.85M
Total Liabilities98.34M1.44M12.93M
Shareholders Equity40.35M18.92M-12.07M
view Recro Pharma Inc balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities7.64M0.46M0.27M
Net Cash From (Used By) Operating Activities8.45M-10.86M-0.81M
Increase (Decrease) In Prop Plant And Equipment-2.41M--
view Recro Pharma Inc cashflow statement

Recro Pharma Inc Stock News - Partner Headlines

Recro Pharma Stock Message Board

Recro Pharma stock lost -0.14 %, and the last close price as of 20 Jan, 2017 is 7.12 for REPH stock. Stock price or share price can be used to find the total market value of a company. Recro Pharma market cap stands at 88.15M as of 20 Jan, 2017. Recro Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Recro Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 94050 on the last trading day, as is evident from Recro Pharma stock chart, and REPH stock quote data. Recro Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.